Celosia Therapeutics
PrivateLast Round
Series A
Nov 28, 2024
Total Funding Raised
$12.92M
Company Overview
Celosia Therapeutics operates in Healthcare & Life Sciences and is based in Sydney. Its latest recorded funding round was a Series A round in November 2024.
Celosia Therapeutics is a biotechnology company that develops precision gene therapies for neurodegenerative diseases, including ALS, FTD, and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celosia Therapeutics Comparables
Compare Celosia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avrion Therapeutics AG | 85% | |
| QurAlis | 79% | |
| VectorY Therapeutics | 78% |
For institutional investors. Book with your work email.
Celosia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 28, 2024 | ||||
| Seed | Oct 31, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Celosia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UniSuper Management | Series A |
| Uniseed | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2024
$11M round led by Uniseed.
- Oct 31, 2022
Raised $2M in seed funding.
For institutional investors. Book with your work email.
Celosia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celosia Therapeutics's valuation, stock price, and market status.
Is Celosia Therapeutics a public or private company?
Celosia Therapeutics is a private company.
What is the current stock price of Celosia Therapeutics?
Celosia Therapeutics is a private company, so its shares have no public market price. Caplight tracks Celosia Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celosia Therapeutics worth (valuation)?
Valuation information for Celosia Therapeutics is not publicly available.
Can I buy Celosia Therapeutics stock?
Celosia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celosia Therapeutics's last funding round?
Celosia Therapeutics's most recent funding round was Series A on November 28, 2024.
Who are the main investors in Celosia Therapeutics?
Key investors in Celosia Therapeutics include Uniseed.
Will Celosia Therapeutics IPO soon?
No public IPO plans have been announced for Celosia Therapeutics.
How can I track Celosia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Celosia Therapeutics's shares on secondary markets.